Alliance Pharma picks up three AstraZeneca antimalarial brands
04:38 EDT 2 Aug 2012 | Proactive Investors
Alliance Pharma (LON:APH) has acquired three anti-malarial brands from AstraZeneca (LON:AZN) for £4.2 million. Wholly-owned subsidiary Alliance Pharmaceuticals will sell Paludrine, Avloclor and Savarine mainly in the UK and France. ..
Original Article: Alliance Pharma picks up three AstraZeneca antimalarial brands
More From BioPortfolio on "Alliance Pharma picks up three AstraZeneca antimalarial brands"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
